Literature DB >> 8935807

Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

T Skarsfeldt1.   

Abstract

A group of novel neuroleptics (e.g. olanzapine, seroquel, sertindole and ziprasidone) and already marketed compounds (e.g. clozapine, haloperidol and risperidone) were tested for acute effect on spatial learning and memory in Morris' water maze task. Young rats were trained for 4 consecutive days (three trials/day) to find a platform situated beneath the water surface. Two compounds, sertindole and seroquel, were without effect on spatial performance, whereas clozapine impaired performance on the first 2 test days but showed no effect compared to the controls on the last 2 test days. Ziprasidone and olanzapine markedly impaired spatial memory without affecting motor function (measured by the swimming speed). Risperidone and haloperidol also impaired performance but in addition both compounds significantly lowered the swimming speed. The present study indicates that several of the compounds impair spatial learning in Morris water maze. This might be of clinical importance in the treatment of schizophrenics, as many of these patients already show severe cognitive deficits. Therefore, certain antipsychotics could worsen the preexisting memory deficits in schizophrenic patients and this aspect should be considered before antipsychotic treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8935807     DOI: 10.1007/bf02245612

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

Review 1.  Psychopharmacological effects in the radial-arm maze.

Authors:  E D Levin
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

2.  Place navigation impaired in rats with hippocampal lesions.

Authors:  R G Morris; P Garrud; J N Rawlins; J O'Keefe
Journal:  Nature       Date:  1982-06-24       Impact factor: 49.962

3.  Schizophrenia, memory, and anticholinergic drugs.

Authors:  C D Frith
Journal:  J Abnorm Psychol       Date:  1984-08

4.  Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.

Authors:  B M Migler; E J Warawa; J B Malick
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Do neuroleptics impair learning in schizophrenic patients?

Authors:  T R Cutmore; R J Beninger
Journal:  Schizophr Res       Date:  1990 May-Jun       Impact factor: 4.939

6.  Neuroleptic drug effects on cognitive function in schizophrenia.

Authors:  J M Cleghorn; R D Kaplan; B Szechtman; H Szechtman; G M Brown
Journal:  Schizophr Res       Date:  1990 May-Jun       Impact factor: 4.939

7.  Differential effects of scopolamine on working and reference memory depend upon level of training.

Authors:  R G Lydon; S Nakajima
Journal:  Pharmacol Biochem Behav       Date:  1992-10       Impact factor: 3.533

8.  Developments of a water-maze procedure for studying spatial learning in the rat.

Authors:  R Morris
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

9.  Assessment of a cholinergic contribution to chlordiazepoxide-induced deficits of place learning in the Morris water maze.

Authors:  R K McNamara; R W Skelton
Journal:  Pharmacol Biochem Behav       Date:  1992-03       Impact factor: 3.533

10.  Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine.

Authors:  J Arnt
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

View more
  24 in total

1.  Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task.

Authors:  Ee Peng Lim; Vivek Verma; Rajini Nagarajah; Gavin S Dawe
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

2.  Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits.

Authors:  Ann N Hoffman; Jeffrey P Cheng; Ross D Zafonte; Anthony E Kline
Journal:  Life Sci       Date:  2008-08-31       Impact factor: 5.037

Review 3.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Treating cognitive dysfunction in patients with schizophrenia.

Authors:  C A Galletly; C R Clark; A C MacFarlane
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

5.  Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice.

Authors:  Stephanie J Klenotich; Mariel P Seiglie; Matthew S McMurray; Jamie D Roitman; Daniel Le Grange; Priya Dugad; Stephanie C Dulawa
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

6.  Comparison of the effects of antipsychotics on a delayed radial maze task in the rat.

Authors:  Mary C Wolff; J David Leander
Journal:  Psychopharmacology (Berl)       Date:  2003-04-23       Impact factor: 4.530

7.  Superior effects of quetiapine compared with aripiprazole and iloperidone on MK-801-induced olfactory memory impairment in female mice.

Authors:  Ahmet Mutlu; Oguz Mutlu; Guner Ulak; Furuzan Akar; Havva Kaya; Faruk Erden; Pelin Tanyeri
Journal:  Biomed Rep       Date:  2017-03-23

Review 8.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.

Authors:  Edward D Levin; Amir H Rezvani
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

9.  Emerging role of sertindole in the management of schizophrenia.

Authors:  Stephanie L Cincotta; Joshua S Rodefer
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 10.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.